Alkermes Plc

Alkermes Plc Current Ratio

The Current Ratio of Alkermes Plc (ALKS) as of Nov 19, 2026 is 3.04. In the previous year, Current Ratio was 2.86 — a change of 6.55% (higher).

Current Ratio

3.04

YoY

6.55%

Last updated:

Current Ratio of Alkermes Plc is 2024 3.04 . Current Ratio of Alkermes Plc was 2023 2.86 . It decreases by 6.55% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alkermes Plc Stock analysis

What does Alkermes Plc do? Alkermes Plc is a leading biopharmaceutical company specializing in the development of innovative drugs for serious diseases since its establishment in 1987. The company is headquartered in Dublin, Ireland, and employs over 2,000 people worldwide. Alkermes Plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alkermes Plc stock

Current Ratio of Alkermes Plc is 3.04 in 2024.

Current Ratio of Alkermes Plc changed from 2.86 to 3.04, representing a 6.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Alkermes Plc since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Alkermes Plc with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Alkermes Plc

All Key Metrics — Alkermes Plc